Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Lymphocyte antigen 6 family member G5B (LY6G5B) is a human protein encoded by the LY6G5B gene, which is located in the major histocompatibility complex (MHC) class III region on chromosome 6[1][2]. LY6G5B is part of the Ly6/uPAR superfamily of cysteine-rich proteins, which typically feature a three-fingered LU domain. Unlike many family members that are GPI-anchored cell-surface proteins, LY6G5B appears to be a secreted protein and may act as a ligand for receptors on undifferentiated hematopoietic cells, suggesting roles in cell–cell communication and regulating hematopoietic cell differentiation[2][4][6]. The LY6G5B locus is subject to complex post-transcriptional regulation, and genetic studies have associated the broader region with autoimmune disease susceptibility, although direct functional links remain uncertain[2]. LY6G5B has also been implicated in Poirier-Bienvenu neurodevelopmental syndrome[1]. There are no reports of LY6G5B as a direct therapeutic target nor of drugs interacting with this protein.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Lymphocyte antigen 6 family member G5B (LY6G5B).